– SET Index closed at 1,637.22 points, decreased 4.25 points or 0.26% with a trading value of 57.2 billion baht. The analyst stated that the Thai stock market traded lower as other Asian markets were mixed on Friday due to no major catalyst to boost the sentiment despite the report of FDA’s approval on Merck’s antiviral Covid-19 pill. Meanwhile, investors are taking a break on the stock markets as holidays approach.
In addition, the analyst expected next week’s session to move narrowly and should start being lively again next year. Nevertheless, there could be some support from the purchase of SSF and RMF, giving a support level at 1,630 points and a resistance level at 1,645 points.
– A selloff worth 2.6 billion baht from Local Institutions and Individuals pressured SET Index by 4.25 points.
– The U.S. on Thursday authorized Merck & CO.’s antiviral COVID-19 pill for certain high-risk adult patients. The approval came a day after the FDA approved similar but more effective treatment from Pfizer.
– Chinese telecommunication giant Huawei released details on a vehicle with specs it claims to beat the Model Y. However, the company noted it will not make the cars on their own. The company earlier has been working with automakers on car technology such as autonomous driving.
– The Bank of Thailand on Friday said it has delayed its plan to test the central bank digital currency (CBDC) for the public in 2022.
– KTBST expected MAKRO to surge well-above THB50 per share, reflecting true fundamentals and valuation from the capital increase.
– Central Group made an official announcement on the investment in Selfridges Group while Central Retail Corporation is considering to take part in this acquisition.
– Stocks in Focus on December 24, 2021: EPG (Krungsri Securities TP at ฿15.00/share) and SCC (Maybank Securities TP at ฿520.00/share).
